Have your own idea? Try our Stock Screener
In the last week, the Biotech industry is up 1.1%, with TYK Medicines up 37%. In the past year, the industry is down 28%. As for the next few years, earnings are expected to grow by 28% per annum.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 29 Aug 2024 | HK$337.3b | HK$53.7b | -HK$18,758,882,140.47 | 11.2x | -18x | 6.3x |
Sat, 27 Jul 2024 | HK$314.0b | HK$49.7b | -HK$19,476,048,887.59 | 11.7x | -16.1x | 6.3x |
Mon, 24 Jun 2024 | HK$332.5b | HK$49.7b | -HK$19,449,051,702.56 | 11.4x | -17.1x | 6.7x |
Wed, 22 May 2024 | HK$361.7b | HK$49.8b | -HK$19,368,355,572.35 | 12.2x | -18.7x | 7.3x |
Fri, 19 Apr 2024 | HK$322.4b | HK$49.6b | -HK$19,911,350,266.52 | 10.8x | -16.2x | 6.5x |
Sun, 17 Mar 2024 | HK$366.5b | HK$47.2b | -HK$20,445,921,301.34 | 17.6x | -17.9x | 7.8x |
Tue, 13 Feb 2024 | HK$321.6b | HK$46.8b | -HK$20,175,287,948.53 | 15.6x | -15.9x | 6.9x |
Thu, 11 Jan 2024 | HK$382.9b | HK$46.9b | -HK$20,242,897,600.00 | 18x | -18.9x | 8.2x |
Sat, 09 Dec 2023 | HK$399.9b | HK$46.9b | -HK$20,242,488,582.00 | 17.7x | -19.8x | 8.5x |
Mon, 06 Nov 2023 | HK$413.3b | HK$45.2b | -HK$18,919,413,159.00 | 12.9x | -21.8x | 9.2x |
Wed, 04 Oct 2023 | HK$400.6b | HK$45.0b | -HK$19,139,886,127.00 | 13.7x | -20.9x | 8.9x |
Fri, 01 Sep 2023 | HK$390.1b | HK$43.5b | -HK$16,489,702,446.00 | 15x | -23.7x | 9x |
Sun, 30 Jul 2023 | HK$427.8b | HK$35.5b | -HK$23,380,251,031.00 | 28x | -18.3x | 12x |
Tue, 27 Jun 2023 | HK$393.4b | HK$35.4b | -HK$23,246,705,446.00 | 24.9x | -16.9x | 11.1x |
Thu, 25 May 2023 | HK$426.2b | HK$36.1b | -HK$23,813,255,373.00 | 29.5x | -17.9x | 11.8x |
Sat, 22 Apr 2023 | HK$441.4b | HK$37.0b | -HK$24,142,920,851.00 | 18.5x | -18.3x | 11.9x |
Mon, 20 Mar 2023 | HK$405.8b | HK$32.4b | -HK$35,346,503,379.00 | 22.9x | -11.5x | 12.5x |
Wed, 15 Feb 2023 | HK$440.1b | HK$34.8b | -HK$35,187,293,822.00 | 31.4x | -12.5x | 12.6x |
Fri, 13 Jan 2023 | HK$444.2b | HK$34.9b | -HK$35,324,662,057.00 | 28.7x | -12.6x | 12.7x |
Sun, 11 Dec 2022 | HK$393.0b | HK$33.6b | -HK$33,953,988,397.00 | 24.6x | -11.6x | 11.7x |
Tue, 08 Nov 2022 | HK$364.0b | HK$33.8b | -HK$32,491,041,863.00 | 18.5x | -11.2x | 10.8x |
Thu, 06 Oct 2022 | HK$298.5b | HK$34.0b | -HK$32,534,977,825.00 | 19x | -9.2x | 8.8x |
Sat, 03 Sep 2022 | HK$332.7b | HK$34.5b | -HK$33,849,516,320.00 | 15.6x | -9.8x | 9.6x |
Mon, 01 Aug 2022 | HK$328.6b | HK$32.9b | -HK$46,359,653,984.00 | 13x | -7.1x | 10x |
Wed, 29 Jun 2022 | HK$387.5b | HK$33.1b | -HK$46,680,283,718.00 | 15.3x | -8.3x | 11.7x |
Fri, 27 May 2022 | HK$321.4b | HK$34.3b | -HK$46,256,256,982.00 | 12.8x | -6.9x | 9.4x |
Sun, 24 Apr 2022 | HK$331.6b | HK$35.8b | -HK$45,369,217,033.00 | 12.9x | -7.3x | 9.3x |
Tue, 22 Mar 2022 | HK$325.4b | HK$34.8b | -HK$33,336,593,534.00 | 13.3x | -9.8x | 9.4x |
Thu, 17 Feb 2022 | HK$311.6b | HK$31.2b | -HK$31,981,474,931.00 | 12.6x | -9.7x | 10x |
Sat, 15 Jan 2022 | HK$379.3b | HK$31.1b | -HK$31,825,549,632.00 | 13.3x | -11.9x | 12.2x |
Mon, 13 Dec 2021 | HK$480.7b | HK$31.1b | -HK$31,827,233,997.00 | 13.5x | -15.1x | 15.5x |
Wed, 10 Nov 2021 | HK$447.8b | HK$30.9b | -HK$31,620,779,940.00 | 13.8x | -14.2x | 14.5x |
Fri, 08 Oct 2021 | HK$497.1b | HK$30.5b | -HK$31,550,708,496.00 | 15.3x | -15.8x | 16.3x |
Sun, 05 Sep 2021 | HK$529.2b | HK$30.2b | -HK$32,058,827,347.35 | 17.5x | -16.5x | 17.5x |
-16.5x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 2.06% | |
Healthcare | -2.38% | |
Biotech | 1.13% | |
Biotech | 1.13% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2410 TYK Medicines | HK$22.10 | 36.8% +HK$2.2b | n/a | PE-18.4x | |
6855 Ascentage Pharma Group International | HK$33.25 | 19.2% +HK$1.7b | 34.1% | PS10.4x | |
1801 Innovent Biologics | HK$44.10 | 1.5% +HK$1.1b | 22.7% | PS10.6x | |
9969 InnoCare Pharma | HK$5.04 | 12.5% +HK$987.0m | -27.2% | PS10.4x | |
1952 Everest Medicines | HK$20.95 | 13.2% +HK$786.1m | 15.0% | PS48.8x |